205 results on '"Bozovic, Ivo"'
Search Results
2. Bulbar-onset amyotrophic lateral sclerosis in a patient with genetically confirmed Huntington’s disease: a case study
3. Myotonic dystrophy type 1 in the COVID-19 era
4. Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2
5. COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis
6. Clinical score for early diagnosis of myotonic dystrophy type 2
7. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
8. Employment status of patients with Charcot-Marie-Tooth type 1A
9. Long-term outcome in patients with myasthenia gravis: one decade longitudinal study
10. Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot–Marie–Tooth disease type 1A
11. Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy
12. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
13. The influence of the COVID-19 pandemic on patients with chronic inflammatory demyelinating polyradiculoneuropathy
14. Longitudinal study of neuropathic pain in patients with Guillain-Barré syndrome
15. Video head impulse gain is impaired in myotonic dystrophy types 1 and 2.
16. Self-reported autonomic dysfunction in a recovery phase of Guillain-Barré syndrome
17. Disability and quality of life in Guillain-Barré syndrome – Longitudinal study
18. Quality of life in patients with polyneuropathy associated with different types of monoclonal gammopathy of undetermined significance
19. Neuropathic pain in patients with Charcot-Marie-Tooth type 1A
20. Cerebral Amyloid Angiopathy-Related Inflammation (CAA-rI): Three Heterogeneous Case Reports and a Focused Literature Review
21. Quality of life in patients with multifocal motor neuropathy from Serbia
22. Responsiveness of 2 Different Ability Outcome Measures in Guillain-Barré Syndrome
23. Cytokine Gene Polymorphisms in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
24. Correction to: Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy
25. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
26. Cerebral Amyloid Angiopathy-Related Inflammation (CAA-rI): Three Heterogeneous Case Reports and a Focused Literature Review
27. Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia
28. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy
29. Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies
30. Clinical score for early diagnosis of myotonic dystrophy type 2
31. COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis
32. Downregulation of LKB1/AMPK Signaling in Blood Mononuclear Cells Is Associated with the Severity of Guillain–Barre Syndrome
33. Neuromuscular disease‐specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy
34. A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy
35. Physical and Mental Aspects of Quality of Life in Patients With Charcot-Marie-Tooth Disease Type 1A
36. Assessment of the neuropathic component in a chronic low back pain syndrome
37. Video head impulse test findings in patients with amyotrophic lateral sclerosis
38. Cognitive function assessment in patients with myotonic dystrophy type 2
39. Long-term outcome in patients with myasthenia gravis: one decade longitudinal study
40. Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy: A European collaborative study
41. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
42. Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy:a European collaborative study
43. Fatigue in myotonic dystrophy type 1: a seven-year prospective study
44. Employment status of patients with Charcot-Marie-Tooth type 1A
45. Neuropathic pain as independent predictor of worse quality of life in patients with diabetic neuropathy
46. Psychometric longitudinal evaluation of the Chronic Acquired Polyneuropathy Patient‐Reported Index ( CAPPRI ) in patients with chronic inflammatory demyelinating polyneuropathy
47. Longitudinal study of neuropathic pain in patients with Guillain-Barré syndrome
48. Incidence and mortality rates of Guillain‐Barré syndrome in Serbia
49. Chronic inflammatory demyelinating polyneuropathy associated with diabetes: a European multicentre comparative reappraisal
50. Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot–Marie–Tooth disease type 1A
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.